|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||18.83 - 19.00|
|52-week range||15.85 - 19.65|
|PE ratio (TTM)||17.56|
|Earnings date||19 Feb 2018 - 23 Feb 2018|
|Forward dividend & yield||0.45 (2.41%)|
|1y target est||19.59|
RELX PLC and RELX N.V. (the "Companies") announce in compliance with the EU Market Abuse Regulation that they will implement an irrevocable, non-discretionary programme to repurchase their respective ordinary shares up to the value of £125 million in total between 26 July 2018 and 24 October 2018 (the "Programme"). Combined, since 2 January 2018, the Companies have purchased 33.8 million shares at a total cost of approximately £525 million, leaving a further £175 million of the previously announced full year total of £700 million to be completed by year end. Pending the expected completion on 8 September 2018 of RELX Group’s corporate simplification, for the period from 26 July 2018 through 5 September 2018, the ratio of the respective ordinary shares to be bought back by each of the Companies over the course of this period will be set by reference to the Companies’ respective economic interests in RELX Group plc. Beginning on 10 September 2018, the Programme will continue with only RELX PLC shares being repurchased.
Attractive stocks have exceptional fundamentals. In the case of RELX NV (ENXTAM:REN), there’s is a well-regarded dividend payer with a a great track record of delivering benchmark-beating performance. Below, I’veRead More...
There is a lot to be liked about RELX PLC (LSE:REL) as an income stock, over the past 10 years it has returned an average of 3.00% per year. TheRead More...
On 15 February 2018, RELX PLC and RELX NV announced a proposed further simplification of RELX Group’s corporate structure, moving from the current dual parent holding company structure to a single parent company. The simplification follows the significant measures which were completed in 2015 and is a natural next step for RELX Group, removing complexity and increasing transparency. The proposed simplification will be effected under the cross-border merger regulations in the UK and the Netherlands.
New unit expands OHG's footprint in world's second largest pharmaceutical market; Takao Ozawa to lead as Managing Director NEW YORK , March 27, 2018 /PRNewswire/ -- Omnicom Health Group, part of Omnicom ...
Another startup in the area of cyber security has been snapped up as platform businesses serving enterprises look for more ways of securing their own networks and working with customers to secure theirs.